CD8A and neoplasm: The clinical impact of PDAC-infiltrating T lymphocytes has also been demonstrated in a recent report, indicating that a high Immunoscore, which is characterized by elevated densities of CD3+ and CD8+ T cells in both the tumor center and invasive margin, is significantly associated with better disease-specific survival (DSS) and OS [57].